Co-Diagnostics, Inc.
CODX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001692415
No open-market purchases or sales by Co-Diagnostics, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $1.85M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Co-Diagnostics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Co-Diagnostics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Serbin Richard S | Director | 10,751 | May 27, 2026 | 2 |
| Nelson James B | Director | 10,668 | May 27, 2026 | 2 |
| Egan Dwight H | Chief Executive Officer | 27,893 | May 27, 2026 | 2 |
| Murphy Edward L. | Director | 11,084 | May 27, 2026 | 2 |
| Durenard Eugene | Director | 10,668 | May 27, 2026 | 2 |
| Brown Brian Lee | Chief Financial Officer | 22,379 | May 27, 2026 | 2 |
| Abbott Richard David | President | 3,417 | May 27, 2026 | 2 |
| Murphy Ted | Director | 224,167 | Aug 15, 2025 | 0 |
| Satterfield Brent | Former Chief Science Officer | – | Aug 19, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2023 (view filing) | Mar 20 | 1 day | Brown Brian LeeChief Financial Officer | PPurchase | +3.00K | $1.90 | +$5.70K | +4.1%76.2K after | |
| Sep 22, 2021 (view filing) | Sep 8 | 14 daysLate | Durenard EugeneDirector | SSale | −2.00K | $10.46 | −$20.9K | −100.0%0 after |